Imagion Biosystems Limited

ASX:IBXDA Stock Report

Market Cap: AU$10.9m

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Imagion Biosystems Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Isaac Bright

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureless than a year
CEO ownershipn/a
Management average tenureno data
Board average tenure4.7yrs

Recent management updates

Recent updates


CEO

Isaac Bright

less than a year

Tenure

Dr. Isaac J. Bright, M.D. is Chief Executive Officer and Managing Director of Imagion Biosystems Limited since June 20, 2023 and serves as its Director since November 13, 2023. He was Co-Founder, Chief Exe...


Board Members

NamePositionTenureCompensationOwnership
Isaac Bright
MD, CEO & Directorno datano datano data
David Ludvigson
Non Executive Director6.7yrsAU$49.32k0.042%
A$ 4.6k
Paul Grint
Member of Scientific Advisory Board4.1yrsno datano data
Dianne Angus
Non-Executive Director3.5yrsAU$45.84k0.025%
A$ 2.7k
Robert Proulx
Non-Executive Chairman6.9yrsAU$574.54k0.47%
A$ 51.6k
John Hazle
Chairman of Scientific Advisory Board5.3yrsAU$17.80kno data
Michael Harsh
Non-Executive Director6.8yrsAU$49.32k0.020%
A$ 2.2k
Robert Ivkov
Member of Scientific Advisory Board4.1yrsno datano data
Andrew Scott
Member of Scientific Advisory Board4.1yrsno datano data
Jovanka Naumoska
Non Executive Director6.9yrsAU$45.84k0.022%
A$ 2.4k
Mark Van Asten
Non Executive Director6.9yrsAU$45.84k0.047%
A$ 5.1k
Lisa Horvath
Member of Scientific Advisory Board4.1yrsno datano data

4.7yrs

Average Tenure

65yo

Average Age

Experienced Board: IBXDA's board of directors are considered experienced (4.7 years average tenure).